On Monday, Aquestive Therapeutics Inc (NASDAQ: AQST) was -6.70% drop from the session before settling in for the closing price of $5.52. A 52-week range for AQST has been $1.41 – $6.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -4.81% over the last five years. When this article was written, the company’s average yearly earnings per share was at -225.00%. With a float of $79.37 million, this company’s outstanding shares have now reached $91.06 million.
The firm has a total of 135 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.49%, operating margin of -26.03%, and the pretax margin is -44.14%.
Aquestive Therapeutics Inc (AQST) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aquestive Therapeutics Inc stocks. The insider ownership of Aquestive Therapeutics Inc is 12.84%, while institutional ownership is 39.65%. The most recent insider transaction that took place on Mar 15 ’24, was worth 300,000. In this transaction Chief Innovation/Tech Officer of this company sold 50,000 shares at a rate of $6.00, taking the stock ownership to the 984,476 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Chief Innovation/Tech Officer sold 25,000 for $5.19, making the entire transaction worth $129,685. This insider now owns 1,040,371 shares in total.
Aquestive Therapeutics Inc (AQST) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.03 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -225.00% per share during the next fiscal year.
Aquestive Therapeutics Inc (NASDAQ: AQST) Trading Performance Indicators
You can see what Aquestive Therapeutics Inc (AQST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Aquestive Therapeutics Inc (AQST)
Analysing the last 5-days average volume posted by the [Aquestive Therapeutics Inc, AQST], we can find that recorded value of 1.54 million was lower than the volume posted last year of 1.75 million. As of the previous 9 days, the stock’s Stochastic %D was 52.66%. Additionally, its Average True Range was 0.30.
During the past 100 days, Aquestive Therapeutics Inc’s (AQST) raw stochastic average was set at 81.74%, which indicates a significant increase from 41.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.65% in the past 14 days, which was lower than the 70.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.90, while its 200-day Moving Average is $3.79. Now, the first resistance to watch is $5.41. This is followed by the second major resistance level at $5.66. The third major resistance level sits at $5.81. If the price goes on to break the first support level at $5.01, it is likely to go to the next support level at $4.86. Now, if the price goes above the second support level, the third support stands at $4.61.
Aquestive Therapeutics Inc (NASDAQ: AQST) Key Stats
There are 91,060K outstanding shares of the company, which has a market capitalization of 471.52 million. As of now, sales total 50,580 K while income totals -7,870 K. Its latest quarter income was 20,100 K while its last quarter net income were -2,750 K.
